参考文献:1.Ramakrishna G, Rooke TW, Cooper LT (2003) Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light. Vasc Med 8:203–210CrossRef PubMed 2.Vinchi F, Muckenthaler MU, Da Silva MC, Balla G, Balla J, Jeney V (2014) Atherogenesis and iron: from epidemiology to cellular level. Front Pharmacol 5:94PubMedCentral CrossRef PubMed 3.Drueke T, Witko-Sarsat V, Massy Z et al (2002) Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 106:2212–2217CrossRef PubMed 4.Wolff B, Volzke H, Ludemann J et al (2004) Association between high serum ferritin levels and carotid atherosclerosis in the study of health in pomerania (SHIP). Stroke 35:453–457CrossRef PubMed 5.Sullivan JL (1981) Iron and the sex difference in heart disease risk. Lancet 1981(1):1293–1294CrossRef 6.Menke A, Fernandez-Real JM, Muntner P, Guallar E (2009) The association of biomarkers of iron status with peripheral arterial disease in us adults. BMC Cardiovasc Disord 9:34PubMedCentral CrossRef PubMed 7.Morrison HI, Semenciw RM, Mao Y, Wigle DT (1994) Serum iron and risk of fatal acute myocardial infarction. Epidemiology 5:243–246CrossRef PubMed 8.Ramakrishnan U, Kuklina E, Stein AD (2002) Iron stores and cardiovascular disease risk factors in women of reproductive age in the united states. Am J Clin Nutr 76:1256–1260PubMed 9.Baer DM, Tekawa IS, Hurley LB (1994) Iron stores are not associated with acute myocardial infarction. Circulation 89:2915–2918CrossRef PubMed 10.Solymoss BC, Marcil M, Gilfix BM, Gelinas F, Poitras AM, Campeau L (1994) The place of ferritin among risk factors associated with coronary artery disease. Coron Artery Dis 5:231–235CrossRef PubMed 11.Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99:2434–2439CrossRef PubMed 12.Kimoto E, Shoji T, Shinohara K (2003) Preferential stiffening of central over peripheral arteries in type 2 diabetes. Diabetes 52:448–452CrossRef PubMed 13.O’Rourke M (1995) Mechanical principles in arterial disease. Hypertension 26:2–9CrossRef PubMed 14.Yamashina A, Tomiyama H, Arai T et al (2003) Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 26:615–622CrossRef PubMed 15.Chuang SY, Chen CH, Cheng CM, Chou P (2005) Combined use of brachial-ankle pulse wave velocity and ankle achial index for fast assessment of arteriosclerosis and atherosclerosis in a community. Int J Cardiol 98:99–105CrossRef PubMed 16.Kim DH, Kim J, Kim JM, Lee AY (2008) Increased brachial-ankle pulse wave velocity is independently associated with risk of cerebral ischemic small vessel disease in elderly hypertensive patients. Clin Neurol Neurosurg 110:599–604CrossRef PubMed 17.Kitahara T, Ono K, Tsuchida A (2005) Impact of brachial-ankle pulse wave velocity and ankle achial blood pressure index on mortality in hemodialysis patients. Am J Kidney Dis 46:688–696CrossRef PubMed 18.Kalantar-Zadeh K, Lee GH (2006) The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease? Clin J Am Soc Nephrol 1(Suppl 1):S9–18CrossRef PubMed 19.Senol E, Ersoy A, Erdinc S, Sarandol E, Yurtkuran M (2008) Oxidative stress and ferritin levels in haemodialysis patients. Nephrol Dial Transplant 23:665–672CrossRef PubMed 20.KDOQI (2006) clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47:S11–145CrossRef 21.Byon CH, Javed A, Dai Q et al (2008) Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor runx2 by akt signaling. J Biol Chem 283:15319–15327PubMedCentral CrossRef PubMed 22.Nakahara T, Sato H, Shimizu T (2010) Fibroblast growth factor-2 induces osteogenic differentiation through a runx2 activation in vascular smooth muscle cells. Biochem Biophys Res Commun 394:243–248CrossRef PubMed 23.Neven E, De Schutter TM, Behets GJ, Gupta A, D’Haese PC (2011) Iron and vascular calcification. Is there a link? Nephrol Dial Transplant 26:1137–1145CrossRef PubMed 24.Rocha LA, Barreto DV, Barreto FC (2009) Serum ferritin level remains a reliable marker of bone marrow iron stores evaluated by histomorphometry in hemodialysis patients. Clin J Am Soc Nephrol 24:105–109CrossRef 25.Lim PS, Wei YH, Yu YL, Kho B (1999) Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. Nephrol Dial Transplant 14:2680–2687CrossRef PubMed 26.Kuo KL, Hung SC, Wei YH, Tarng DC (2008) Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. J Am Soc Nephrol 219:1817–1826CrossRef 27.Martin-Malo A, Merino A, Carracedo J (2012) Effects of intravenous iron on mononuclear cells during the haemodialysis session. Nephrol Dial Transplant 27:2465–2471CrossRef PubMed 28.de Vecchi AF, Novembrino C, Lonati S, Ippolito S, Bamonti F (2007) Two different modalities of iron gluconate i.v. administration: effects on iron, oxidative and inflammatory status in peritoneal dialysis patients. Nephrol Dial Transplant 22:1709–1713CrossRef PubMed 29.Tomiyama H, Yamashina A, Arai T et al (2003) Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement—a survey of 12517 subjects. Atherosclerosis 166:303–309CrossRef PubMed 30.Nomura K, Nakao M, Karita K, Nishikitani M, Yano E (2005) Association between work-related psychological stress and arterial stiffness measured by brachial-ankle pulse-wave velocity in young Japanese males from an information service company. Scand J Work Environ Health 31:352–359CrossRef PubMed 31.Choi KM, Lee KW, Seo JA et al (2004) Relationship between brachial-ankle pulse wave velocity and cardiovascular risk factors of the metabolic syndrome. Diabetes Res Clin Pract 66:57–61CrossRef PubMed 32.Fujiwara Y, Chaves P, Takahashi R et al (2004) Relationships between brachial-ankle pulse wave velocity and conventional atherosclerotic risk factors in community-dwelling people. Prev Med 39:1135–1142CrossRef PubMed 33.Rambod M, Kovesdy CP, Kalantar-Zadeh K (2008) Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation. Clin J Am Soc Nephrol 3:1691–1701PubMedCentral CrossRef PubMed 34.Kalantar-Zadeh K, Rodriguez RA, Humphreys MH (2004) Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrol Dial Transplant 19:141–149CrossRef PubMed
作者单位:Kao-Chang Lin (1) (2) Meng-Yi Tsai (3) Chun-Ling Chi (4) Lai-King Yu (5) Li-Hsueh Huang (5) Chien-An Chen (5)
1. Department of Biotechnology, Southern Taiwan University, Tainan, Taiwan 2. Department of Neurology, Chi-Mei Medical Center, Tainan, Taiwan 3. Department of Hematology and Oncology, Tainan Sinlau Hospital, Tainan, Taiwan 4. Department of Family Medicine, Tainan Sinlau Hospital, Tainan, Taiwan 5. Division of Nephrology, Tainan Sinlau Hospital, No. 57, 1 Sec., Dongmen Rd., Tainan, Taiwan
刊物类别:Medicine
刊物主题:Medicine & Public Health Nephrology Urology and Andrology
出版者:Springer Netherlands
ISSN:1573-2584
文摘
Background Iron may contribute to vascular injury through reactive oxygen species. Hemodialysis patients frequently receive iron supply for correction of anemia and are at a high risk of cardiovascular disease. We tested the relationship between iron status and change in arterial stiffness in hemodialysis patients.